 |  |  |  |  |
 |  |  |  |  | | |
| |  |
| PRIME NEWS |  |
 |
 |

|
|
Syngene has announced that its first Dyversity 6 innovative 2D gel imaging system has been installed at the Singapore Massachusetts Institute of Technology Alliance for Research and Technology Center
  |
|
|
 |
|
|
 |

|
|
Living Cell Technologies has applied to list its ADR program on the International OTCQX to increase the Companys exposure to US investors
  |
|
|
 |
|
|
|
| | |  Read the latest biotechnology news & articles, trends and analysis, biotechnology business and investment opportunities, research & development breakthroughs, bio technology product features, event listings, job postings and market research studies on bio technology in BioSpectrum Asia.  | | | | |  |  |  |  |  |
|
| 
 |
 |
 |
 |
 |
 |
 |
NEWS |
 |
 |
|
 |
Calando gets Chinese patent on RNAi technology
 |
|
| Calando Pharmaceuticals, a majority owned subsidiary of Arrowhead Research Corporation has received Chinese patent called Methods and compositions for therapeutic use of RNA interference |
|
 |
|
|
 |
Stem Cell Sciences gets US stem cell media patent
 |
|
| StemCell has said that the US Patent Office has granted its patent for technology that improves the efficiency of the culture and derivation of embryonic stem cells which leads to an increased purity of the cells |
|
 |
|
|
|
 |
 |
 |
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
FEATURES |
 |
 |
|
 |
Australia's promising 3
 |
|
| BioSpectrum has named year 2008 as Year of the Entrepreneur. We are celebrating it by bringing you a series profiling entrepreneurs from the Asia Pacific region. The first in the series had three hot and happening companies from Singapore |
|
 |
|
|
 |
WHO 2008-15 Global Plan
 |
|
| There are over a dozen diseases, prevalent mainly in tropical areas of the planet, inhabited by people living in abject poverty. These diseases together affect one-sixth or over one billion people |
|
 |
|
|
|
 |
 |
 |
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
PEOPLE |
 |
 |
|
 |
Covance elects Mr Joseph Scodari to Board of Directors
 |
|
| Covance, with headquarters in Princeton, New Jersey and a comprehensive drug development services company has elected Mr Joseph C. Scodari to its Board of Directors. He has a distinguished 34-year career as a key leader in the pharmaceutical |
|
 |
|
|
|
|
|
 |
 |
 |
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
EVENTS |
 |
 |
|
 |
China Medicine to represent Guangzhou at BIO 2008
 |
|
| China Medicine, a distributor and developer of ethical and OTC drugs in China was selected by the Guangzhou Technology Bureau to represent Guangzhou city's biotechnology industry at BIO International Convention |
|
 |
|
|
|
|
|
 |
 |
 |
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
R & D |
 |
 |
|
|
|
 |
Scientists now link microRNA sequences to cancer
 |
|
| Invitrogen and BioServe announced that their technologies identified noncoding RNAs that were differentially expressed in healthy and diseased tissue. These micro ribonucleic acid sequences were either up or down |
|
 |
|
|
|
 |
 |
 |
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
POLICIES |
 |
 |
|
|
|
 |
RegeneRx gets ophthalmic patent in Hong Kong
 |
|
| RegeneRx Biopharmaceuticals has received a patent from the Hong Kong Intellectual Property Department using T4, analogues, isoforms and derivatives to accelerate corneal wound healing and reverse or inhibit eye degeneration |
|
 |
|
|
|
 |
 |
 |
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
PRODUCTS |
 |
 |
|
 |
Enterix launches lab-based InSure FIT test
 |
|
| Enterix, a wholly-owned subsidiary of Quest Diagnostics and US-based biotechnology company announced the availability of the InSure Quik F I T fecal immunochemical test, a point-of-care version of the company's lab-based InSure FIT |
|
 |
|
|
|
|
|
 |
 |
 |
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
TRENDS & ANALYSIS |
 |
 |
|
|
|
 |
Patent expiry opens huge potential for Biosimilars
 |
|
| Some of the biggest-selling biologics developed during the boom years in biotech of the 1980's, have lost patent protection in the US in 2007 or will shortly. This opens up huge potential market for biosimilars, if regulatory hurdles can be overcome |
|
 |
|
|
|
 |
 |
 |
 |
|
|
|
|
|  |  |  | | | | |  |  |  |
|
|
 |
|  | |  |  |  |  | | |